Author: Fiona Craig

Tatton Asset Management Plc (LSE:TAM) reported annual net inflows of £2.8 billion, outperforming expectations and indicating that full-year results are likely to come in at the upper end of market forecasts. Analysts noted that flows exceeded their projections, reinforcing the strength of the group’s performance over the period.

Total assets under management and influence increased 11% year-on-year to £24.2 billion for the year ended 31 March. Monthly net inflows averaged £234 million, in line with guidance, with momentum building in the second half, where inflows rose to £242 million per month compared with £225 million in the first half.

Investment performance and market movements contributed £2.456 billion during the year. However, a previously disclosed client mandate loss led to £3.329 billion in outflows in January 2026. Excluding this impact, underlying assets under management grew by 26.8%, highlighting the strength of core business inflows.

The group also expanded its distribution network, adding 108 independent financial adviser firms to reach a total of 1,218. Its Paradigm mortgages division delivered £17.5 billion in lending completions, up from £14.2 billion a year earlier, while the number of mortgage member firms increased to 2,014 from 1,915.

Analysts at RBC Capital Markets said underlying net inflows were around 10% ahead of their £2.5 billion estimate, with total assets under management and influence exceeding their forecast by approximately 3%. They also noted stronger inflows in the second half and suggested that the company would need lower monthly inflows than current levels to achieve its £30 billion target by 2029.

Chief executive Paul Hogarth said “against a volatile and challenging macroeconomic and geopolitical backdrop, I am particularly pleased with the consistency of our underlying net inflows throughout the year, with a stronger second half contributing to a full-year average of £234 million per month and at the top of our guidance range.”

Great Portland Estates (LSE:GPE) reported a strong finish to its financial year, completing £70.9 million in annual rental agreements across 88 new leases and renewals. Market lettings were achieved at an average of 10.3% above the March 2025 estimated rental value (ERV), highlighting continued demand for high-quality office space.

In the fourth quarter alone, the company secured £24.4 million in rent from 28 leasing transactions, with deals completed at 15.8% above ERV. Performance was supported by strong occupier interest in fully managed and fitted workspaces, including a significant 52,300 square foot pre-let to Quantexa at Minerva House, also known as The Delft, which was agreed well above ERV expectations.

Rent reviews during the period were also robust, settling 49% above previous passing rent and 11.1% ahead of ERV benchmarks. The group completed its largest development at 2 Aldermanbury Square, which has been fully pre-let to Clifford Chance, further reinforcing demand for prime, centrally located office space.

On the capital recycling front, Great Portland Estates completed £490 million of disposals at 2% above book value, including the sale of wells&more, W1 to Felberg Capital for £172 million. The transaction reflected a 5% net initial yield and a valuation of £1,483 per square foot.

“Despite a volatile macroeconomic backdrop, this has been an excellent finish to the year,” said Toby Courtauld.

“We signed £24.4 million of leases in the quarter and delivered a record £70.9m of deals for the year, 10.3% ahead of ERV, reflecting the strength of demand for high quality, well located space and the momentum in our Fully Managed offer.”

Iofina plc (LSE:IOF) delivered a record-breaking first quarter in 2026, producing 178.9 metric tonnes of crystalline iodine from its eight IOsorb facilities in Oklahoma—up 44% year-on-year. The increase was driven by additional capacity brought online in late 2025, alongside favourable conditions such as warmer brine temperatures. Strong market demand has kept iodine spot prices above $70 per kilogram, prompting the company to upgrade its outlook, with first-half production now expected to reach around 385 metric tonnes, ahead of previous guidance. The group also noted it has not been impacted by current global supply chain disruptions.

The company continues to expand its production footprint, progressing construction of a larger IOsorb plant in the Permian Basin in partnership with Western Midstream Partners. The new facility is expected to come online in late Q3 2026 and will represent the group’s ninth plant. Management highlighted that the strong start to the year, combined with a growing pipeline of opportunities across the Permian and Oklahoma, positions Iofina for a sustained period of growth. Full-year 2025 financial results are scheduled for release in early May.

From an investment perspective, Iofina’s outlook is supported by solid financial stability and ongoing strategic expansion initiatives. While technical indicators suggest some caution due to overbought conditions, the company’s growth trajectory and valuation remain appealing.

More about Iofina plc

Iofina plc is a vertically integrated iodine producer and specialty chemicals company, operating through its Iofina Resources and Iofina Chemical divisions. It is the second-largest iodine producer in North America, with eight IOsorb plants currently in operation in Oklahoma and a ninth under development in the Permian Basin. The company also manufactures a range of halogen-based and non-iodine specialty chemical products for global markets.

hVIVO (LSE:HVO) reported a challenging 2025, with revenue falling to £46.8 million from £62.7 million and adjusted EBITDA declining to £1.4 million. The downturn reflects a transitional year for the business alongside broader macro pressures across the pharmaceutical services sector. Profitability and cash levels were notably lower, although the company ended the year with a £30 million contracted order book and expects a return to growth in 2026, with revenue forecast to increase by high single digits, weighted toward the second half.

During the year, hVIVO expanded its capabilities through the acquisition and integration of two Clinical Research Units in Germany from CRS, as well as UK-based Cryostore. These additions broaden its offering into early-phase trials, cardiometabolic and immunology studies, and temperature-controlled storage. The group has also reorganised into four core service lines and introduced a validated human metapneumovirus (hMPV) challenge model. Further progress includes securing multi-site trial agreements and an influenza challenge study with Traws Pharma, while unifying its operations under a single hVIVO brand to reflect its evolution into a more diversified clinical development partner.

Management believes the expanded platform and increased cross-selling between its UK and German operations will reduce reliance on infectious disease challenge trials and support margin recovery over time. A strong pipeline across all service lines, combined with ongoing discussions for additional contracts, underpins confidence in long-term growth and a stronger competitive position within the sector.

From an investment standpoint, the outlook reflects a mix of improving fundamentals and lingering challenges. While revenue growth prospects and a relatively low leverage position are supportive, recent financial performance has been weak. Technical indicators show positive momentum, though the share price remains below key moving averages, suggesting potential resistance. Valuation appears attractive, with a low price-to-earnings ratio and a modest dividend yield offering appeal to value-oriented investors.

More about hVIVO plc

hVIVO plc is a UK-based, full-service clinical development company and a global leader in human challenge trials, working with several of the world’s largest biopharmaceutical firms. The group provides an integrated platform covering early-stage development, including preclinical planning, first-in-human studies, Phase II trials, and specialist laboratory services, across facilities in the UK and Germany.

Its four core divisions—Consulting, Clinical Trials, Human Challenge Trials, and Laboratories—are designed to accelerate drug development timelines. hVIVO also operates extensive participant recruitment capabilities, including the FluCamp platform, and runs the world’s largest quarantine facility for controlled human infection studies in London.

Anglo Asian Mining (LSE:AAZ) reported a strong first quarter for 2026, with copper production rising sharply to 3,711 tonnes, supported by solid performance at its Gedabek mine and the continued ramp-up of operations at Demirli. Gold output remained broadly steady at 6,062 ounces, while silver production increased to 42,796 ounces. The group generated $45.6 million from concentrate sales and sold 4,100 ounces of gold bullion at favourable prices, helping lift its net cash position by $15.4 million to $17.7 million. It also reported $30.8 million in unsold inventory on its balance sheet.

Management highlighted that the strong quarterly performance reflects progress in its strategy to grow copper production and reposition the business as a diversified, copper-focused producer. The ramp-up of newer assets is playing a key role in this transition. A shift from net debt to net cash, along with the repayment of advances from offtake partner Trafigura, has strengthened the company’s financial position and flexibility as it advances its development pipeline in Azerbaijan. This may appeal to investors seeking exposure to rising global demand for copper.

Despite the operational momentum, the company’s broader outlook remains weighed down by weaker financial metrics, including declining revenue, negative margins, and reduced free cash flow. Valuation is also difficult to assess due to the lack of consistent profitability. However, technical indicators offer some support, with the share price trending above key moving averages and showing positive momentum.

More about Anglo Asian Mining

Anglo Asian Mining is an AIM-listed producer of copper, gold, and silver, with operations and exploration assets located in Azerbaijan. Its current producing mines include Gedabek, Gilar, and Demirli, and the company aims to bring additional deposits—such as Xarxar, Garadag, and Zafar—into production by 2030 as part of its strategy to evolve into a mid-tier, multi-asset metals producer.

S4Capital (LSE:SFOR) has confirmed it will release its first-quarter 2026 trading update on 7 May, as the group continues to focus on delivering technology-driven, always-on marketing solutions to a broad global client base. The company positions itself as a systems integrator for the post-agency era, combining its Marketing Services and Technology Services capabilities to help brands deliver real-time, data-led engagement.

As part of its regular investor communications, the group will host a webcast and conference call in London at 09:00 BST on the day of the update. The session will give investors and analysts the opportunity to hear management’s insights and ask questions. The announcement reflects S4Capital’s continued commitment to transparency as it works toward its strategic objectives, including rebalancing its geographic exposure and revenue mix across business lines in a fast-changing digital advertising market.

From an investment perspective, the outlook remains mixed. Improvements in debt levels and stronger recent cash generation are positive developments, but these are offset by a longer-term decline in revenue and ongoing net losses. Technical indicators point to an upward trend, although overbought conditions suggest potential short-term volatility. Valuation is constrained by the lack of profitability, while recent updates indicate efforts to stabilise performance and maintain financial discipline amid continued pressure on revenue and margins.

More about S4 Capital Plc

S4Capital is a digital-first advertising, marketing, and technology services group serving multinational, regional, and local clients, as well as influencer-led brands. The company operates through its Marketing Services and Technology Services divisions, using a unified structure designed to deliver integrated, real-time solutions in the evolving digital landscape.

The group employs around 6,350 people across 33 countries, with approximately 80% of revenue generated in the Americas, 15% from Europe, the Middle East and Africa, and 5% from Asia-Pacific. Over time, it aims to shift this regional mix to 60:20:20, while also increasing the contribution of its Technology Services arm relative to its core Marketing Services business, under the leadership of Martin Sorrell.

Hollywood Bowl Group (LSE:BOWL) delivered a solid first-half performance, with revenue increasing 9.5% year-on-year to £141.5 million. Growth was supported by both its UK and Canadian operations, alongside a 1.9% rise in like-for-like revenue. The business continued to benefit from steady demand for affordable, family-oriented leisure activities, while maintaining strong gross margins and disciplined cost control, including long-term hedging of electricity costs.

The company also pushed ahead with its expansion plans, opening a new site in Edmonton and bringing its total estate to 77 centres in the UK and 16 in Canada. A further three openings are planned for the second half, with a well-developed pipeline extending into 2027 and beyond. Backed by a strong balance sheet, £8.6 million in capital expenditure, and a net cash position of £26 million—along with access to an undrawn £25 million facility—management remains confident in delivering continued profitable growth into FY2026 and the longer term.

From an investment perspective, the outlook is supported by robust financial performance and a relatively attractive valuation. While technical indicators point to some near-term softness, these are offset by solid fundamentals and a compelling dividend yield.

More about Hollywood Bowl

Hollywood Bowl Group plc operates the largest ten-pin bowling brands across the UK and Canada, offering accessible, family-focused leisure experiences through a growing network of centres. The group also runs a Canadian-based equipment supply and maintenance business, giving it an integrated position within the bowling and wider family entertainment market.

Hunting PLC (LSE:HTG) reported a steady start to 2026, delivering first-quarter EBITDA of $23.2 million with a margin of 10%, and maintaining its full-year EBITDA guidance in the range of $145 million to $155 million. The group expects earnings to be more heavily weighted toward the second half. Performance was led by stronger-than-expected results in North American perforating systems, while seasonal working capital movements and ongoing share buybacks reduced net cash to $8.3 million.

The company’s order book has expanded to approximately $428.8 million, driven by robust OCTG tender activity and significant subsea contract wins. These include $63.5 million in titanium stress joint orders tied to a project in Guyana. Hunting is also continuing to diversify, growing its advanced manufacturing offering for industrial and aerospace customers. Alongside this, management is pushing ahead with a $15 million cost reduction programme, which includes closing the Fordoun facility and consolidating its EMEA and Asia Pacific operations into a unified International division from 2027. The group is also exploring bolt-on acquisitions in subsea to enhance its long-term growth profile, despite geopolitical uncertainties in regions such as the Middle East.

From an investment perspective, the outlook is supported by stronger operating performance, a resilient balance sheet, and reaffirmed FY26 guidance, alongside a healthy pipeline of tenders and ongoing shareholder returns through buybacks and dividends. However, these positives are balanced by cash flow volatility—particularly the decline seen in 2025—limited near-term visibility beyond the current order book, and only moderate valuation appeal for a business exposed to cyclical end markets.

More about Hunting

Hunting PLC is a global engineering group specialising in precision manufacturing and services for the energy and industrial sectors. Headquartered in the UK and listed in London, with a corporate base in Houston, the company operates across North America, EMEA, Asia Pacific, and subsea markets. Its customer base spans oil and gas, power generation, aerospace, and defence industries.